{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-092318","form_type":"8-K","ticker":"APVO","cik":"0001671584","company_name":"Aptevo Therapeutics Inc.","filed_at":"2025-07-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.602386+00:00","generated_at":"2026-05-18T10:00:41.175608+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Aptevo regains Nasdaq compliance with $15.9M equity raise","bullets":["Received Nasdaq notice confirming compliance with minimum $2.5M stockholders' equity rule.","Raised ~$15.9M gross proceeds from equity capital in quarter ended June 30, 2025.","Company previously disclosed non-compliance for quarter ended March 31, 2025.","Believes stockholders' equity now exceeds $2.5M threshold."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-092318","json":"https://secwatch.observer/filing/0000950170-25-092318.json","markdown":"https://secwatch.observer/filing/0000950170-25-092318.md","text":"https://secwatch.observer/filing/0000950170-25-092318.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025092318/0000950170-25-092318-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025092318/apvo-20250701.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T10:00:41.175608+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}